Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Healthequity (HQY) EBT Margin (2016 - 2025)

Historic EBT Margin for Healthequity (HQY) over the last 13 years, with Q4 2025 value amounting to 20.96%.

  • Healthequity's EBT Margin rose 188900.0% to 20.96% in Q4 2025 from the same period last year, while for Oct 2025 it was 19.1%, marking a year-over-year increase of 90300.0%. This contributed to the annual value of 9.67% for FY2025, which is 21600.0% up from last year.
  • According to the latest figures from Q4 2025, Healthequity's EBT Margin is 20.96%, which was up 188900.0% from 23.95% recorded in Q3 2025.
  • In the past 5 years, Healthequity's EBT Margin ranged from a high of 23.95% in Q3 2025 and a low of 21.53% during Q1 2022
  • For the 5-year period, Healthequity's EBT Margin averaged around 4.09%, with its median value being 3.08% (2024).
  • Its EBT Margin has fluctuated over the past 5 years, first tumbled by -208100bps in 2022, then surged by 215300bps in 2023.
  • Quarter analysis of 5 years shows Healthequity's EBT Margin stood at 5.07% in 2021, then surged by 44bps to 2.86% in 2022, then soared by 396bps to 8.46% in 2023, then plummeted by -76bps to 2.07% in 2024, then surged by 913bps to 20.96% in 2025.
  • Its last three reported values are 20.96% in Q4 2025, 23.95% for Q3 2025, and 21.45% during Q2 2025.